Blog
Impact of the CVS GLP-1 formulary change: Trends in switching
Impact of the CVS GLP-1 formulary change: Trends in prescribing
One-year cardiovascular outcomes after GLP-1 discontinuation
Truveta experts: Biomarker testing trends in metastatic non-small cell lung cancer (NSCLC)
Multiple sclerosis: Real-world treatment patterns and outcomes
ISPE 2025: Real-world data survival patterns in glioblastoma patients
ISPE 2025: Active surveillance of mosquito-borne diseases in the United States
